Previous Article | Next Article ![]()
Infection and Immunity, September 2006, p. 5292-5301, Vol. 74, No. 9
0019-9567/06/$08.00+0 doi:10.1128/IAI.02024-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Parasitic Diseases Unit, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan,1 Department of Veterinary Teaching Hospital and Internal Medicine, Faculty of Agriculture, University of Miyazaki, Gakuen Kibanadai Nishi, Miyazaki 889-2192, Japan,2 Faculty of Veterinary Medicine, Bogor Agricultural University, Jalan Agatis Campus IPB Darmaga Bogor 16680, Jawa Barat, Indonesia,3 Department of Parasitology, Graduate School of Medical Science, Kyushu University, 3-1-1 Higashi-ku, Maidashi, Fukuoka 812-8582, Japan,4 Division of Immunology, Institute for Animal Health, Compton, Nr. Newbury, Berkshire RG20 7NN, United Kingdom5
Received 16 December 2005/ Returned for modification 1 March 2006/ Accepted 30 June 2006
|
|
|---|
) and tumor necrosis factor alpha (TNF-
) and decreased transforming growth factor ß (TGF-ß) production. Addition of IFN-
and TNF-
or supernatants obtained from cultured IEL from E. vermiformis-infected mice reduced transepithelial electrical resistance (TER) in a confluent CMT93 cell monolayer, a murine intestine-derived epithelial line, but antibodies against these cytokines suppressed the decline of TER. Moreover, TGF-ß attenuated the damage of epithelial monolayer and changes in TER caused by IFN-
and TNF-
. The expression of junctional molecules by EC was decreased when IEL produced a high level of IFN-
and TNF-
and a low level of TGF-ß in E. vermiformis-infected mice. Interestingly, IEL constantly expressed junctional molecules and a coculture of EC with IEL increased TER. These results suggest that IEL play important multifunctional roles not only in protection of the epithelium against E. vermiformis-induced change by cytokine production but also in direct interaction with the epithelial barrier when intra-EC junctions are down-regulated. |
|
|---|
Eimeria vermiformis, a murine pathogen, has been widely used as a coccidial model in the laboratory to elucidate the mechanism of host protection against primary and secondary infections. T cells bearing T-cell receptor
ß (TCR
ß) (
ß T cells) are necessary for protecting the host against infection, whereas 
T cells are important for repairing lesions as regulatory cells (31). It is assumed that the effects of T cells in protection against E. vermiformis are partially mediated by cytokines, such as gamma interferon (IFN-
) and tumor necrosis factor alpha (TNF-
), because these cytokines have been detected in E. vermiformis-infected hosts (27). IFN-
-deficient or -depleted mice are highly susceptible to infection (40, 41). IFN-
is produced in E. vermiformis-infected hosts, especially at the site of infection. Although intestinal intraepithelial lymphocytes (IEL) reside at a basolateral site of the intestinal epithelium, no studies have examined the role of cytokine production by IEL during E. vermiformis infection.
The epithelial lining of the gastrointestinal tract forms a regulated, selectively permeable barrier between the luminal contents and the underlying tissue compartments by junctional molecules. The junction complex constitutes the primary barrier against the paracellular penetration of intestinal microorganisms. In particular, tight junction complexes, which are formed by occludin, a plasma membrane protein, and zonula occludens (ZO), its cytoplasmic partner protein, are linked to the actin cytoskeleton (23). Selective disturbance of tight junction complexes by microorganisms results in the rapid decrease of transepithelial electrical resistance (TER) of the EC layer, resulting in increasing paracellular permeability (20). Recently, we demonstrated that IEL express a range of junctional molecules associated with EC (15). Both IFN-
and TNF-
are elevated in the inflammatory mucosa, showing a contribution to the proinflammatory cascade, which may be involved in barrier disruption (24, 26). Hence, we examined cytokine production by IEL and their involvement in epithelial function to understand the contribution of IEL in maintaining an epithelial barrier during enteric infection.
|
|
|---|
Infection by E. vermiformis. E. vermiformis was passaged in mice, and oocysts were purified and sporulated (33). After microscopical scoring of stocks for sporulation, mice were given 100 or 500 sporulated oocysts in 100 µl of water by oral gavage. During infection, feces were collected every 3 days. Oocysts were counted on McMaster chambers after salt flotation.
Histological analysis. Intestines were fixed with 4% paraformaldehyde in phosphate-buffered saline and embedded in paraffin. The paraffin sections were stained with hematoxylin-eosin.
Cell preparation. Following E. vermiformis infection, mice were euthanized and both IEL and EC in the small intestine were isolated and prepared every 3 days according to a modification of previously published methods (12). In brief, after the small intestine was divided into the upper one-third (including the duodenum) and the lower two-thirds (from the jejunum to the ileum), dissected small segments of each part were incubated at 37°C for 30 min in RPMI 1640 medium (Sigma Chemical Co., Missouri) containing 10% fetal calf serum and 1 mM dithiothreitol with vigorous shaking. The tissue suspension was passaged through a nylon mesh to remove debris and centrifuged through a 25%-40%-75% discontinuous Percoll (Sigma) gradient at 600 x g at 20°C for 20 min. The cells collected from the interface of 40%-75% and 25%-40% were IEL and EC, respectively.
Cell culture and cytokine analysis.
Whole and sorted IEL (1 x 106/ml) were added to a 96-well plate precoated with 2.5 µg anti-CD3
monoclonal antibody (MAb) (145-2C11; BD Pharmingen) and were cultured for 48 h in RPMI 1640 supplemented with 10% fetal calf serum, 100 U/ml penicillin, and 100 U/ml streptomycin. The supernatants were collected to estimate the cytokine contents. The contents of cytokines in the culture supernatant were assayed by an enzyme-linked immunosorbent assay (ELISA) system using mouse IFN-
, interleukin-4 (IL-4), and TNF-
(e-bioscience, San Diego, Calif.) and transforming growth factor ß (TGF-ß) (Biosource International Inc., Camarillo, Calif.). ELISA systems were used according to the manufacturer's instructions.
Analysis of mRNA expression of junctional molecules. Total RNA was extracted from isolated cells using the RNeasy Mini kit (QIAGEN, Valencia, Calif.) and primed with 20 pmol of a random primer in mixtures for reverse transcription. The synthesized cDNA was amplified by PCR using primers specific for the murine junctional molecules and ß-actin cDNA sequence. The primer sets were described as previously reported for reverse transcription-PCR (RT-PCR) (15): ZO-1, sense, 5'-CAA AGC CCA CCA AGG TCA C-3', and antisense, 5'-TCT CTT TCC GAG GCA TTA GCA-3'; occludin, sense, 5'-CAG GGC TCT TTG GAG GAA-3', and antisense, 5'-TAC ACG ATC GTG GCA ATA AAC-3'; junctional adhesion molecule (JAM), sense, 5'-GAC CCG GAA GGA CAA TGG AGA-3', and antisense, 5'-AGG ACA GCT GCC ACG ATG C-3'; ß-catenin, sense, 5'-ACT GTT CTA CGC CAT CAC GAC-3', and antisense, 5'-CCT CTA TGC CAC CCA CTT G-3'; E-cadherin, sense, 5'-GCA CAT ATG TAG CTC TCA TC-3', and antisense, 5'-CCT TCA CAG TCA CAC ACA TG-3'; desmoglein 2, sense, 5'-GGA CTT TGG AAA CGG ACT TC-3', and antisense, 5'-TCT GTA ATT CCC TTC CCA GTG-3'; connexin 26, sense, 5'-GCT CAC GGT CCT CTT CAT CT-3', and antisense, 5'-ACC CTT CGA TAC GGA CCT TCT-3'; ß-actin, sense, 5'-TGG AAT CCT GTG GCA TCC ATG AAA C-3', and antisense, 5'-TAA AAC GCA GCT CAG TAA CAG TCC G-3'. For quantitative analysis of mRNA, the synthesized cDNA was amplified by using primers and probes specific for ZO-1 and occludin and ß-actin cDNA sequence (TaqMan gene expression assays; Applied Biosystems, Foster City, Calif.) according to the manufacturer's instructions. Quantitative real-time PCR was performed by using an ABI Prism 7000 sequence detector system (Applied Biosystems, Foster City, Calif.). Results are expressed as difference (n-fold) from the expression of ß-actin.
Western blotting analysis. Western blotting analysis was performed as previously reported (15). In brief, isolated EC and IEL were washed with cold phosphate-buffered saline and lysed in sample buffer (125 mM Tris, pH 6.8, 2% sodium dodecyl sulfate, 10% glycerol, and 2% 2-mercaptoethanol) at 95°C for 7 min, followed by sonication for 1 min. Proteins were electrophoresed and transferred to a polyvinylidene difluoride membrane. The membrane was blocked with 10% skimmed milk in Tris-buffered saline-Tween for 1 h, incubated with each Ab against junctional proteins overnight at 4°C, and then incubated with appropriate horseradish peroxidase-labeled secondary Abs (affinity-purified goat anti-rabbit, goat anti-mouse, or goat anti-rat immunoglobulin G) that were obtained from Jackson ImmunoResearch Labs Inc. (West Grove, Pa.). Bound antibodies were visualized by enhancement with chemiluminescence substrate (Pierce, Rockford, Ill.). The primary Abs against junctional molecules used in Western blotting were as follows: rabbit antioccludin (Zymed; cytoplasmic domain specific), rabbit antioccludin (Santa Cruz; extracellular/cytoplasmic domain), mouse anti-ß-catenin (BD Transduction Laboratories), goat anti-JAM1 (Santa Cruz Biotechnology, Inc., Santa Cruz, Calif.), goat anti-E-cadherin (extracellular domain specific; R&D Systems Inc., Minneapolis, MN), and mouse anti-desmoglein (BD Transduction Laboratories). Mouse anti-ß-actin Ab was purchased from Sigma (St. Louis, Mo.).
Fluorescence-activated cell sorting analysis.
IEL were stained with fluorescein isothiocyanate-conjugated TCR
(GL3), phycoerythrin-conjugated TCRß (H57-597), and allophycocyanin-conjugated CD3
(145-2C11) MAbs as described previously (13). Flow cytometry analysis was performed on a FACScalibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ). All MAbs were purchased from BD Pharmingen (San Jose, Calif.).
Measurement of TER.
Functional integrity of tight junctions in cell layers established on filter inserts was assessed by measuring TER using a Millicel ERS volt-ohmmeter (Millipore Corp., Bedford, Mass.). The CMT93 cell line, a mouse intestine-derived epithelial line, was obtained from the American Type Culture Collection (CCL223). CMT93 cells were seeded on the apical chamber of a transwell by using the BD BioCoat Intestinal Epithelium Differentiation Environment (BD Biosciences, Bedford, Mass.) for 72 h in a 5% CO2 incubator according to the manufacturer's instructions and developed a TER around 450
/cm2. After that, culture medium was removed from the apical and basolateral chamber and replaced with either fresh medium or medium containing IFN-
(1, 10, or 100 ng/ml) (Chemicon, Temecula, Calif.), TNF-
(1, 10, or 100 ng/ml) (Peprotech EC, London, United Kingdom), or TGF-ß (2.5 ng/ml) (Roche Diagnostics, Mannheim, Germany) and cultured for 48 h. To examine the effect of cytokines produced by IEL in E. vermiformis-infected mice on the barrier of CMT93 cells, mice were euthanized at each day after E. vermiformis infection and IEL were prepared. IEL were stimulated with plate-bound anti-CD3 MAb for 48 h, and the supernatant was recovered. The culture medium from the apical and basolateral chamber was removed and replaced with the supernatant. For neutralization of IFN-
and TNF-
, anti-IFN-
and anti-TNF-
MAbs (BioLegend, San Diego, Calif.) were added to culture wells at 10 µg/ml. The TER without a cellular monolayer was consistently less than 70
/cm2. For primary EC culture, EC were isolated as described previously (12) and 5 x 105 cells were seeded on the apical chamber of a transwell by using the BD BioCoat Intestinal Epithelium Differentiation Environment for 6 days to develop a TER around 200
/cm2. A varying number of IEL were added onto cultured EC on day 4 after the start of culture, and 2 days later, TER was measured. Values of TER are expressed as percentages of the initial resistance as follows: % of the initial resistance = [(resistance from each point) (resistance from a blank)/(resistance from nontreated cells) (resistance from a blank)] x 100.
Depletion of IFN-
or TNF-
in vivo.
Five hundred micrograms of anti-IFN-
MAb (R4-6A2) (21) or 50 µg of anti-TNF-
MAb (1F3F3; Bender MedSystems Products, Vienna, Austria) or rat immunoglobulin G (Cappel, North Carolina) was administered intraperitoneally into the mice on days 1, 3, and 7 after infection.
Statistical analysis. Student's t test was used to determine the significant differences. A P value of less than 0.05 was taken as significant.
|
|
|---|
![]() View larger version (72K): [in a new window] |
FIG. 1. Hematoxylin-and-eosin-stained transverse sections of the small intestine on day 9 p.i. Mice were given 100 or 500 oocysts of E. vermiformis. On day 9 p.i., the small intestine was removed and divided into parts, the upper (including duodenum [a and d]) and the lower (jejunum [b and e] and ileum [c and f]) (magnification, x200).
|
![]() View larger version (15K): [in a new window] |
FIG. 2. Oocyst output of E. vermiformis in C57BL/6 mice. Mice were orally infected with 100 oocysts of E. vermiformis, and the oocyst output was determined every 3 days. Three mice were used in each point. Values represent the mean ± standard deviation of three individual experiments.
|
ß (
ß IEL) and TCR
(
IEL) (10). We also examined the changes in the population of
ß IEL and 
IEL during E. vermiformis infection. As shown in Fig. 3B, a larger number of 
IEL were present in the upper segment before infection and then decreased until day 15 p.i., whereas
ß IEL increased following infection. Both
ß and 
IEL in the upper segment almost recovered to the preinfection level on day 20 p.i. In the lower segment,
ß IEL and 
IEL were nearly equal in number.
ß IEL increased until day 15 p.i., whereas 
IEL decreased. The number of 
IEL was lower than that of
ß IEL during infection except for the early stage of infection in the upper segment (days 0 to 3 p.i.). Both
ß and 
IEL in the lower segment of the small intestine recovered to the initial level on day 20 p.i. These results indicate that the total number of IEL increased at around a peak of oocyst production, which was due to an increase in
ß IEL rather than 
IEL.
![]() View larger version (15K): [in a new window] |
FIG. 3. Cell number of IEL following infection with E. vermiformis. (A) Total IEL number was counted by staining with trypan blue. (B) Population of IEL bearing TCR ß and TCR![]() of the upper and lower parts following infection. IEL were stained with fluorescein isothiocyanate-conjugated TCR![]() MAb, PE-conjugated TCRß MAb, and allophycocyanin-conjugated CD3 MAb. The TCR ß and TCR![]() expression was gated on CD3+ cells. Three mice were used in each point. Values represent the mean ± standard deviation of three individual experiments in a triplicate assay. Asterisks represent statistically significant differences (P < 0.05).
|
, a typical Th1-type cytokine, has been shown to be important against primary infection with E. vermiformis (35, 41). E. vermiformis development occurs within EC; hence, IEL, which reside between EC, are well placed to influence parasite development and to maintain the integrity of the EC barrier. IEL are reported to produce both Th1 and Th2 cytokines (48); thus, it is important to determine which cytokines are produced by IEL during E. vermiformis infection. We examined the production of cytokines IFN-
, IL-4 (a typical Th2-type cytokine), and TNF-
(an inflammatory cytokine) by IEL in the upper and lower segments of the gut during infection. As shown in Fig. 4, IFN-
, IL-4, and TNF-
were increased in IEL after infection, reached a peak on days 6 to 12 p.i., and then recovered to the initial level on day 20 p.i. In contrast, TGF-ß (a Th3-type and immunoregulatory cytokine) decreased and reached a minimum on days 12 to 15 p.i and recovered to the initial level on day 20 p.i. These changes in the cytokines occurred after oocyst shedding (Fig. 2). TGF-ß was produced in greater quantities in the upper segment than in the lower segment of the small intestine, and large quantities of TNF-
were produced in the lower segment during infection. |
View larger version (11K): [in a new window] |
FIG. 4. Changes in cytokine production of IEL following infection with E. vermiformis. Freshly isolated IEL at each time point were cultured with plate-bound anti-CD3 MAb for 48 h, and the supernatants were collected to determine the concentration of each cytokine by ELISA for IFN- , IL-4, TNF- , and TGF-ß. Three mice were used in each point. Values represent the mean ± standard deviation of three individual experiments in a triplicate assay. Asterisks represent statistically significant differences (*, P < 0.05; **, P < 0.01).
|
or TNF-
(Fig. 5A). TER was further decreased when CMT93 cells were cultured in combination with IFN-
and TNF-
(Fig. 5B). As TGF-ß has been known not only to repair mucosal injury but also to preserve the integrity of the intestinal mucosa (6, 28), we examined the effect of TGF-ß on TER in CMT93 cells. Although TER in CMT93 cells was decreased by the addition of TNF-
or IFN-
alone (Fig. 5A), it was increased by the addition of TNF-
plus TGF-ß or IFN-
plus TGF-ß (Fig. 5B). TER was not affected by addition of TGF-ß alone. Antibodies against TNF-
or IFN-
suppressed the decline of TER in CMT93 cells. Furthermore, when CMT93 cells were cultured with the supernatant of IEL derived from the upper or lower segment of the small intestine from noninfected mice, TER decreased to 84% or 82%, respectively (Fig. 5C). TER in CMT93 cells decreased to 68% when CMT93 cells were cultured with the supernatant obtained from IEL from the upper segment of the infected mice on day 6 p.i. In contrast, TER was more intensively reduced (54%) by exposure to the supernatant of IEL from the lower segment of the infected mice. The decreased TER in CMT93 cells was significantly reversed by the addition of anti-IFN-
and anti-TNF-
Abs, confirming that these cytokines directly affect TER. These results indicate that the epithelial barrier could be impaired through inflammatory cytokines produced by IEL in E. vermiformis-infected mice.
![]() View larger version (17K): [in a new window] |
FIG. 5. Abolishment of TER in an epithelial cell line by inflammatory cytokines produced by IEL. (A) CMT93 cells were exposed to 1 (open circles), 10 (closed circles), and 100 (open squares) ng/ml of recombinant IFN- or TNF- for 24 and 48 h. (B) CMT93 cells were cultured in combination with 10 ng/ml of IFN- and TNF- . for 48 h. CMT93 cells were also cultured with 2.5 ng/ml of TGF-ß1 and IFN- or TNF- (10 ng/ml) for 48 h. (C) CMT93 cells were cultured with supernatants of IEL prepared from mice infected with E. vermiformis on days 3, 6, and 20 p.i. in the presence of immobilized anti-CD3 MAb. Supernatant prepared from mice infected with E. vermiformis on day 6 p.i. was added with 10 µg/ml of anti-IFN- and anti-TNF- Abs to CMT93 cells. These cells were then incubated for 48 h at 37°C for the determination of TER. Values represent the mean ± standard deviation of three individual experiments in a triplicate assay. Asterisks represent statistically significant differences (*, P < 0.05).
|
![]() View larger version (39K): [in a new window] |
FIG. 6. Decreased mRNA expression of junctional molecules in small intestinal EC following infection with E. vermiformis. (A) Total RNA was prepared from EC of small intestine and amplified by RT-PCR. (B) mRNA expression of ZO-1 and occludin was analyzed quantitatively by real-time PCR. Data are presented as the ratio of each time point to day 0 in the upper and lower segment. Asterisks represent statistically significant differences between the upper and lower segments (*, P < 0.05; **, P < 0.01).
|
![]() View larger version (85K): [in a new window] |
FIG. 7. Western blotting analysis for the expression of junctional molecules at the protein level in EC of small intestine. Cell lysate was prepared from small intestinal EC in mice and analyzed by Western blotting as described in Materials and Methods.
|
![]() View larger version (70K): [in a new window] |
FIG. 8. Sustained mRNA expression of junctional molecules in small intestinal IEL following infection with E. vermiformis. After small intestine was separated into upper and lower segments, fresh IEL were obtained. (A) Total RNA was prepared from IEL in the upper and lower parts and amplified by RT-PCR. (B) Western blotting analysis for the expression of junctional molecules at protein level in IEL of small intestine. Cell lysate was prepared from small intestinal IEL in the upper and lower segments and analyzed by Western blotting.
|
and anti-TNF-
Abs confirmed that these cytokines decrease TER in EC in vivo. IEL die easily when separated and cultured in isolation (13). However, we observed that approximately 60% of IEL remained alive at 48 h in the transwell under the present experimental conditions (data not shown). Collectively, these results suggest that IEL contribute to the maintenance of an epithelial barrier in E. vermiformis-infected mice.
![]() View larger version (15K): [in a new window] |
FIG. 9. Increased TER in freshly isolated EC cocultured with IEL from E. vermiformis-infected mice on day 6 p.i. (A) Effect of a varying number of IEL on TER of EC. On day 4 after EC were cultured, IEL were added to EC and TER was measured on day 6. Values represent the mean ± standard deviation of three individual experiments in a triplicate assay. (B) On day 4 after EC were cultured, 1 x 105 IEL were added to EC, and TER was measured with or without 10 µg/ml of anti-IFN- and anti-TNF- Abs on day 6. Values represent the mean ± standard deviation of three individual experiments in a triplicate assay. Asterisks represent statistically significant differences (P < 0.05).
|
and TNF-
on inhibition of growth of E. vermiformis and in exaggeration of epithelial damage.
IFN-
and TNF-
were increased in E. vermiformis-infected mice (Fig. 4), and these cytokines diminished epithelial barrier function (Fig. 5). We examined the role of IFN-
and TNF-
in modulation of intestinal epithelial barrier against E. vermiformis infection by using IFN-
- or TNF-
-depleted mice. As previously reported (41), anti-IFN-
Ab-treated mice produced approximately 10-fold-more oocysts than control Ab-treated mice on day 9 p.i. (Fig. 10A). By contrast, anti-TNF-
Ab-treated mice showed markedly lower levels of oocyst output. Histological analysis revealed that anti-IFN-
Ab-treated mice exhibited more severe intestinal damage than control immunoglobulin G or anti-TNF-
Ab-treated mice did in the lower segment (Fig. 10B). We further examined expression of junctional molecules by EC in anti-IFN-
or -TNF-
Ab-treated mice. Treatment with anti-IFN-
Ab or anti-TNF-
Ab alone failed to recover expression of junctional molecules, which are suppressed by Eimeria infection (Fig. 10C), compared with the level of the expression in noninfected mice (Fig. 6A, day 0 panel). These results suggest that IFN-
is an important cytokine in protective immunity against Eimeria infection and that TNF-
may exacerbate infection. Epithelial damage was affected by the level of infection and also influenced by the activity of cytokines in vivo.
![]() View larger version (49K): [in a new window] |
FIG. 10. Modulation of junctional molecules due to depletion of IFN- or TNF- in vivo. (A) Oocyst output of E. vermiformis in mice treated with anti-IFN- Ab or anti-TNF- Ab in vivo. Mice were orally infected with 100 oocysts of E. vermiformis, and the oocyst output was determined on day 9 p.i. Values represent the mean ± standard deviation of three mice in each group. Asterisks represent statistically significant differences (*, P < 0.05). (B) Hematoxylin-and-eosin-stained transverse sections of the small intestine on day 9 p.i. (magnification, x200). (C) mRNA expression of junctional molecules in small intestinal EC following infection with E. vermiformis. Total RNA was prepared from EC of small intestine and amplified by RT-PCR. IgG, immunoglobulin G.
|
|
|
|---|
It has long been considered that IEL serve a critical role in the mucosal immune system by performing a variety of regulatory functions, including cytokine production, cytotoxic activity, and induction of apoptosis in EC (11, 14, 44, 48). E. vermiformis infects the lower segment of the small intestine in mice (46), and infection-induced inflammation and damage of tissue were restricted to this segment (Fig. 1). We found that the total number of IEL in the upper segment is relatively larger than that in the lower segment even before infection and increases further during E. vermiformis infection (Fig. 3A). Overall the IEL in the murine small intestine contain approximately equal populations bearing TCR
ß and TCR
(10); however, the results of these studies indicated rationalization of the IEL populations with greater numbers of 
IEL in the upper part of the small intestine than in more distal regions (Fig. 3). We have reported that 
T-cell-deficient (C
/) mice are susceptible to trinitrobenzene sulfonic acid-induced colitis and show a fragile small intestine (12), suggesting that the residence of fewer 
IEL in the lower part of the small intestine might cause fragility of the intestinal epithelium. Interestingly, these data might support the possibility that IEL function to prevent the spread of infection or damage to the upper segment because the number of IEL, especially
ß IEL in the upper segment, is higher from day 6 to day 9 p.i. (Fig. 3), and this alteration occurs concurrently with oocyst production (Fig. 1). Our data support the previous report that in adult mice, CD4+
ß T cells play the role of effector cells against primary infection of E. vermiformis, while 
T cells play the role of regulatory cells (31). Moreover, the dynamics of IEL in noninfected regions of the small intestine reveal a level of coordination within the gut T-cell responses more extensive than that previously reported in any system. The effects of this coordination may be an important proactive response to protect uninfected regions of the gut from the potential of an infection spreading within the small intestine.
A transmission electrical microscopy study revealed that the sporozoites of Eimeria spp. actively invaded intestinal EC, which resulted in the disruption of internal cellular organization and extensive tissue damage, including disrupted microvilli (5). Interestingly, sporozoites likely moved from EC to EC at lateral sites because a junction structure, such as the tight junction, was not disturbed at the apical site, whereas that at the lateral or basolateral site was. In this study, decreased expression of occludin and JAM recovered from day 12 to day 15 p.i.; in contrast, E-cadherin and desmoglein 2 decreased from day 3 to day 6 p.i. (Fig. 6 and 7), suggesting that, during the schizogony stage, sporocysts and merozoites might move among adjacent cells, causing the destruction of the junction structure at the lateral site. Furthermore, it is possible that many EC are easily broken and damaged when oocysts break out of the host EC. Our study provides evidence that the expression of junctional proteins at the apical site, such as occludin and JAM, was reduced. We have recently demonstrated that IEL constitutively express junctional molecules, such as occludin and E-cadherin, and that the expression of these proteins is higher in 
IEL than in
ß IEL (15). We showed in this study that IEL, unlike EC, constantly express E-cadherin and occludin during all periods of E. vermiformis infection (Fig. 8). It would be interesting to determine why and how the sporozoites of E. vermiformis prefer to move within restricted sites of the epithelium. For example, Clostridium perfringens enterotoxin binds to claudin 3 and 4, the molecules in the tight junction (9, 43). The surface of Listeria monocytogenes interacts with the extradomain of E-cadherin (19, 25, 37). These reports suggest that junctional molecules may be receptors for invading microorganisms. Therefore, it is likely that E. vermiformis could also bind to certain junctional molecules to move between EC. Further information is needed to prove these hypotheses.
Although eimerian infection is controlled by IFN-
and CD4+ T cells restricted to major histocompatibility complex class II (41), it is noteworthy that IL-4 mRNA was up-regulated during infection. The production of antigen-specific IL-5 was also noted with ex vivo assays (32), and it is clear that a Th1/Th2 mixed cytokine profile is induced by infection. Nonetheless, unlike IFN-
, IL-4 deficiency does not alter the level of oocyst output (41) and the role of Th2-type cytokines in the biology of eimerian infections is unknown, although it might be speculated that these could reduce the level of Th1-type cytokines in the gut, performing a regulatory role to reduce immune-mediated damage.
The disruption of the EC barrier might be also mediated through cytokines that are produced by IEL, a hypothesis supported by the findings of the present study. During the eimerian infection, IEL transiently produced high amounts of IFN-
and TNF-
associated with a decrease in production of TGF-ß, suggesting an interaction between production of these cytokines by IEL and that by EC. IFN-
is well established as an important anti-Eimeria molecule in vitro (34) and in vivo (35, 41), as is the anti-inflammatory role for TGF-ß (17, 29). Hence, our model is that the production of a high amount of IFN-
is involved in parasite killing, whereas the infection is controlled and then resolution of the intestinal lesions is coordinated by IEL and production of TGF-ß. These cytokines are known to be involved in the alteration of junctional molecules. The expression of junctional molecules on the IEL would also help to provide a structural framework for EC recovery and promote close juxtaposition between IEL and the damaged/recovering EC.
IFN-
down-regulates the occludin promoter of the human intestinal cell line HT-29/B6 and modulates junction integrity (24, 26). On the other hand, it is well known that TGF-ß regulates multiple physiological functions in various tissues, including intestinal EC, and that 
IEL can produce TGF-ß (7). Recently, we reported that the transfer of 
IEL to C
/ mice ameliorated trinitrobenzene sulfonic acid-induced colitis mediated by TGF-ß (12). TGF-ß was shown to enhance the barrier function of T84 intestinal epithelial monolayers and to promote intestinal epithelial restitution (6, 28). In our data, the IFN-
-mediated loss of TER in CMT93 cells was normalized by addition of TGF-ß (Fig. 4B). These results strongly support the hypothesis that TGF-ß is necessary for the maintenance of intestinal epithelial integrity. Indeed, TNF-
induces damage in the lower segment of the small intestine after infection and was produced in the greatest amounts from IEL in the infected segment of the small intestine (Fig. 4). Taken together, our results suggest that IEL positively produce Th1-type cytokines, such as IFN-
, to protect the host against E. vermiformis. Moreover, IEL might function to prevent the excessive disruption of the epithelial layer through IEL-derived cytokines by maintaining the expression of junctional molecules and production of TGF-ß. It would also be interesting to determine why junctional molecules expressed by EC are remarkably down-regulated, while those in IEL are maintained during E. vermiformis infection (Fig. 7 and 8). This might be explained by the fact that intestinal EC possess a TNF receptor (TNFR) as well as an IFN-
receptor (1). TNF-
has been shown to down-regulate occludin but not ZO-1 in astrocytes (47). This down-regulation of occludin was entirely mediated by TNFR1. TNFR consists of TNFR1 and TNFR2 (22, 42). TNF-
binds to both receptors; however, TNFR1 is mainly expressed on nonlymphocytes, such as EC and fibroblasts (45). Further studies will be needed to elucidate what kinds of signals from the cytokine receptor are linked to the gene expression of junctional molecules in EC and IEL and how this occurs.
We thank Goro Matsuzaki (University of the Ryukyus, Japan) for carefully reading and providing critical comments. We also thank Noriko Kanemaru for technical assistance and Joko Shigenobu and Ayumi Tanaka for their steadfast support.
|
|
|---|

play a protective role in intestinal inflammation. J. Immunol. 173:1390-1398.
T cells in the primary but not secondary protective immune response against an intestinal parasite. J. Exp. Med. 198:1403-1414.
B activation. J. Neurochem. 78:155-162.[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»